These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition. Cadena-Suárez AR; Hernández-Hernández HA; Alvarado-Vásquez N; Rangel-Escareño C; Sommer B; Negrete-García MC Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743055 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis. Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203 [TBL] [Abstract][Full Text] [Related]
36. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis. Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280 [TBL] [Abstract][Full Text] [Related]
37. R-Spondin-2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior. Munguía-Reyes A; Balderas-Martínez YI; Becerril C; Checa M; Ramírez R; Ortiz B; Meléndez-Zajgla J; Pardo A; Selman M Am J Respir Cell Mol Biol; 2018 Jul; 59(1):65-76. PubMed ID: 29345973 [TBL] [Abstract][Full Text] [Related]